| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600131 | 重组全人源抗RANKL单克隆抗体注射液 | denosumab | Injection | Biological Products(2) | New Drug Application | 2017-02-13 | 菲洋生物科技（吉林）有限公司 | Feiyang Biotechnology (Jilin) Co Ltd | Certificate Issued | 2017-12-21 | view |